Brevard, NC - August 29, 2022

Raybow is attending this three day trade show and conference which gets underway September 7th, 2022. The event was on hiatus due to Covid. The 2022 edition of the show is sold out.

Raybow attended the last edition of the show in 2019. Key executives attending the event include Peter Halkjaer-Knudsen, Executive Vice President, Gerard Scarlator, Head of Business Development - West and Fazal Chaudhry, Director of Business Development - East.

"This has always been a great show for us" said Halkjaer-Knudsen. "It is always nice when we get to meet our clients and suppliers face-to-face."

Peter has been invited to speak on three panel discussions at the event including;

• Wednesday 4:00PM - "Keynote 2022: CMC, API & Global Supply Chain Security in the Post-Pandemic World"
• Thursday 9:00AM - "Small Molecule API Supply Chain Post-Pandemic: Price Inflation, CDMO Capacity Constraints, Raw Materials, Logistical Challenges"
• Thursday 1:30PM - "What's Going On In China? Risk Mitigation, Lockdowns, Ports, Shipping, Reshoring, Chinese Manufacturing Expansion in USA & Europe"

The in-person event runs for 3 days, ending on the 8th. Raybow will round out the year attending Bio Europe October 24th to 26th and CPhI Worldwide in Frankfurt, Germany November 1st through the 3rd.

Raybow PharmaScience is a global Contract Drug and Manufacturing Organization (CDMO) with operations in China, Europe and the U.S. Raybow is focused on providing world class research and development capabilities in the pharmaceutical manufacturing space. Raybow has shown its commitment to the R&D side of the business launching two 10,000 square meter R&D centers in the past 3 years alone and hiring more than 600 new chemists in that same time frame.